CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向：肿瘤 经验分享：12月15日投稿，到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0 偏重的研究方向：综述;血液肿瘤 经验分享：with editor状态持续两个半月，然后直接拒稿，白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向：综述;血液肿瘤 经验分享：with editor一个月、催稿两次，目前还没有消息，服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向：肿瘤;胃癌 经验分享：7.1投了一篇网状meta，7.2 with editor，持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：血液;肿瘤;综述 经验分享：2023.05.26投稿,3天后with editor,过了半个月还是with editor，于是发邮件催了一下， 2023.06.18 under review, 过了两个月还是没音信，就又催杂志社，没回应，本着破罐子破摔的想法，催了主编，没想到很快就给了小修（08.22），08.28返修回去，又是一直with editor，半个月后，还是with editor，等不及，又催了编辑，没反应，再催主编。 终于在2023.09.12 accept。 总结一下，这个杂志社只收综述，而且整个过程会很慢，编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：实体肿瘤;Review;血液肿瘤 经验分享：一审一个月，大修一个半月，小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0 偏重的研究方向：血液学 经验分享：审稿时间大概五个月，提了很多问题很详细，大修一个月，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153284, encodeId=e1d721532844c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：编辑处理一个月拒稿，这杂志的编辑真出生啊，7.13号投稿，期间邮件咨询状态3次全部没有回复，后来给主编发了邮件，第二天就拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2115702113, createdName=ms2000001247099710, createdTime=Thu Aug 17 19:57:43 CST 2023, time=2023-08-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2148767, encodeId=3f292148e67f2, content=他家只收综述么，科研论文不能投么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc148355026, createdName=ms6000001144568928, createdTime=Wed Jul 19 11:21:21 CST 2023, time=2023-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0 经验分享：投稿第二天就显示under review ，是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]

2024-01-31 ms2000000592007598 来自浙江省

偏重的研究方向：肿瘤
经验分享：12月15日投稿，到现在还是with editor

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向：肿瘤 经验分享：12月15日投稿，到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0 偏重的研究方向：综述;血液肿瘤 经验分享：with editor状态持续两个半月，然后直接拒稿，白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向：综述;血液肿瘤 经验分享：with editor一个月、催稿两次，目前还没有消息，服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向：肿瘤;胃癌 经验分享：7.1投了一篇网状meta，7.2 with editor，持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：血液;肿瘤;综述 经验分享：2023.05.26投稿,3天后with editor,过了半个月还是with editor，于是发邮件催了一下， 2023.06.18 under review, 过了两个月还是没音信，就又催杂志社，没回应，本着破罐子破摔的想法，催了主编，没想到很快就给了小修（08.22），08.28返修回去，又是一直with editor，半个月后，还是with editor，等不及，又催了编辑，没反应，再催主编。 终于在2023.09.12 accept。 总结一下，这个杂志社只收综述，而且整个过程会很慢，编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：实体肿瘤;Review;血液肿瘤 经验分享：一审一个月，大修一个半月，小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0 偏重的研究方向：血液学 经验分享：审稿时间大概五个月，提了很多问题很详细，大修一个月，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153284, encodeId=e1d721532844c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：编辑处理一个月拒稿，这杂志的编辑真出生啊，7.13号投稿，期间邮件咨询状态3次全部没有回复，后来给主编发了邮件，第二天就拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2115702113, createdName=ms2000001247099710, createdTime=Thu Aug 17 19:57:43 CST 2023, time=2023-08-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2148767, encodeId=3f292148e67f2, content=他家只收综述么，科研论文不能投么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc148355026, createdName=ms6000001144568928, createdTime=Wed Jul 19 11:21:21 CST 2023, time=2023-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0 经验分享：投稿第二天就显示under review ，是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]

2023-12-17 ms7000000544050302 来自湖北省

审稿速度:3.0
偏重的研究方向：综述;血液肿瘤
经验分享：with editor状态持续两个半月，然后直接拒稿，白白浪费我三个月时间。谨慎投稿吧。

21 0

[GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向：肿瘤 经验分享：12月15日投稿，到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0 偏重的研究方向：综述;血液肿瘤 经验分享：with editor状态持续两个半月，然后直接拒稿，白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向：综述;血液肿瘤 经验分享：with editor一个月、催稿两次，目前还没有消息，服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向：肿瘤;胃癌 经验分享：7.1投了一篇网状meta，7.2 with editor，持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：血液;肿瘤;综述 经验分享：2023.05.26投稿,3天后with editor,过了半个月还是with editor，于是发邮件催了一下， 2023.06.18 under review, 过了两个月还是没音信，就又催杂志社，没回应，本着破罐子破摔的想法，催了主编，没想到很快就给了小修（08.22），08.28返修回去，又是一直with editor，半个月后，还是with editor，等不及，又催了编辑，没反应，再催主编。 终于在2023.09.12 accept。 总结一下，这个杂志社只收综述，而且整个过程会很慢，编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：实体肿瘤;Review;血液肿瘤 经验分享：一审一个月，大修一个半月，小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0 偏重的研究方向：血液学 经验分享：审稿时间大概五个月，提了很多问题很详细，大修一个月，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153284, encodeId=e1d721532844c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：编辑处理一个月拒稿，这杂志的编辑真出生啊，7.13号投稿，期间邮件咨询状态3次全部没有回复，后来给主编发了邮件，第二天就拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2115702113, createdName=ms2000001247099710, createdTime=Thu Aug 17 19:57:43 CST 2023, time=2023-08-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2148767, encodeId=3f292148e67f2, content=他家只收综述么，科研论文不能投么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc148355026, createdName=ms6000001144568928, createdTime=Wed Jul 19 11:21:21 CST 2023, time=2023-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0 经验分享：投稿第二天就显示under review ，是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]

2023-10-18 ms7000000544050302 来自湖北省

偏重的研究方向：综述;血液肿瘤
经验分享：with editor一个月、催稿两次，目前还没有消息，服了。

15 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向：肿瘤 经验分享：12月15日投稿，到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0 偏重的研究方向：综述;血液肿瘤 经验分享：with editor状态持续两个半月，然后直接拒稿，白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向：综述;血液肿瘤 经验分享：with editor一个月、催稿两次，目前还没有消息，服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向：肿瘤;胃癌 经验分享：7.1投了一篇网状meta，7.2 with editor，持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：血液;肿瘤;综述 经验分享：2023.05.26投稿,3天后with editor,过了半个月还是with editor，于是发邮件催了一下， 2023.06.18 under review, 过了两个月还是没音信，就又催杂志社，没回应，本着破罐子破摔的想法，催了主编，没想到很快就给了小修（08.22），08.28返修回去，又是一直with editor，半个月后，还是with editor，等不及，又催了编辑，没反应，再催主编。 终于在2023.09.12 accept。 总结一下，这个杂志社只收综述，而且整个过程会很慢，编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：实体肿瘤;Review;血液肿瘤 经验分享：一审一个月，大修一个半月，小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0 偏重的研究方向：血液学 经验分享：审稿时间大概五个月，提了很多问题很详细，大修一个月，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153284, encodeId=e1d721532844c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：编辑处理一个月拒稿，这杂志的编辑真出生啊，7.13号投稿，期间邮件咨询状态3次全部没有回复，后来给主编发了邮件，第二天就拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2115702113, createdName=ms2000001247099710, createdTime=Thu Aug 17 19:57:43 CST 2023, time=2023-08-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2148767, encodeId=3f292148e67f2, content=他家只收综述么，科研论文不能投么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc148355026, createdName=ms6000001144568928, createdTime=Wed Jul 19 11:21:21 CST 2023, time=2023-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0 经验分享：投稿第二天就显示under review ，是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]

2023-07-04 ms2000002077912665 来自北京

偏重的研究方向：肿瘤;胃癌
经验分享：7.1投了一篇网状meta，7.2 with editor，持续更新

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向：肿瘤 经验分享：12月15日投稿，到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0 偏重的研究方向：综述;血液肿瘤 经验分享：with editor状态持续两个半月，然后直接拒稿，白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向：综述;血液肿瘤 经验分享：with editor一个月、催稿两次，目前还没有消息，服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向：肿瘤;胃癌 经验分享：7.1投了一篇网状meta，7.2 with editor，持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：血液;肿瘤;综述 经验分享：2023.05.26投稿,3天后with editor,过了半个月还是with editor，于是发邮件催了一下， 2023.06.18 under review, 过了两个月还是没音信，就又催杂志社，没回应，本着破罐子破摔的想法，催了主编，没想到很快就给了小修（08.22），08.28返修回去，又是一直with editor，半个月后，还是with editor，等不及，又催了编辑，没反应，再催主编。 终于在2023.09.12 accept。 总结一下，这个杂志社只收综述，而且整个过程会很慢，编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：实体肿瘤;Review;血液肿瘤 经验分享：一审一个月，大修一个半月，小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0 偏重的研究方向：血液学 经验分享：审稿时间大概五个月，提了很多问题很详细，大修一个月，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153284, encodeId=e1d721532844c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：编辑处理一个月拒稿，这杂志的编辑真出生啊，7.13号投稿，期间邮件咨询状态3次全部没有回复，后来给主编发了邮件，第二天就拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2115702113, createdName=ms2000001247099710, createdTime=Thu Aug 17 19:57:43 CST 2023, time=2023-08-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2148767, encodeId=3f292148e67f2, content=他家只收综述么，科研论文不能投么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc148355026, createdName=ms6000001144568928, createdTime=Wed Jul 19 11:21:21 CST 2023, time=2023-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0 经验分享：投稿第二天就显示under review ，是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]

2023-09-13 气管支气管来自江西省

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：血液;肿瘤;综述
经验分享：2023.05.26投稿,3天后with editor,过了半个月还是with editor，于是发邮件催了一下，
2023.06.18 under review, 过了两个月还是没音信，就又催杂志社，没回应，本着破罐子破摔的想法，催了主编，没想到很快就给了小修（08.22），08.28返修回去，又是一直with editor，半个月后，还是with editor，等不及，又催了编辑，没反应，再催主编。
终于在2023.09.12 accept。
总结一下，这个杂志社只收综述，而且整个过程会很慢，编辑很不负责。自行考虑投稿。

30 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向：肿瘤 经验分享：12月15日投稿，到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0 偏重的研究方向：综述;血液肿瘤 经验分享：with editor状态持续两个半月，然后直接拒稿，白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向：综述;血液肿瘤 经验分享：with editor一个月、催稿两次，目前还没有消息，服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向：肿瘤;胃癌 经验分享：7.1投了一篇网状meta，7.2 with editor，持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：血液;肿瘤;综述 经验分享：2023.05.26投稿,3天后with editor,过了半个月还是with editor，于是发邮件催了一下， 2023.06.18 under review, 过了两个月还是没音信，就又催杂志社，没回应，本着破罐子破摔的想法，催了主编，没想到很快就给了小修（08.22），08.28返修回去，又是一直with editor，半个月后，还是with editor，等不及，又催了编辑，没反应，再催主编。 终于在2023.09.12 accept。 总结一下，这个杂志社只收综述，而且整个过程会很慢，编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：实体肿瘤;Review;血液肿瘤 经验分享：一审一个月，大修一个半月，小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0 偏重的研究方向：血液学 经验分享：审稿时间大概五个月，提了很多问题很详细，大修一个月，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153284, encodeId=e1d721532844c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：编辑处理一个月拒稿，这杂志的编辑真出生啊，7.13号投稿，期间邮件咨询状态3次全部没有回复，后来给主编发了邮件，第二天就拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2115702113, createdName=ms2000001247099710, createdTime=Thu Aug 17 19:57:43 CST 2023, time=2023-08-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2148767, encodeId=3f292148e67f2, content=他家只收综述么，科研论文不能投么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc148355026, createdName=ms6000001144568928, createdTime=Wed Jul 19 11:21:21 CST 2023, time=2023-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0 经验分享：投稿第二天就显示under review ，是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]

2022-02-04 capoex

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：实体肿瘤;Review;血液肿瘤
经验分享：一审一个月，大修一个半月，小修后就接收了。

61 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向：肿瘤 经验分享：12月15日投稿，到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0 偏重的研究方向：综述;血液肿瘤 经验分享：with editor状态持续两个半月，然后直接拒稿，白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向：综述;血液肿瘤 经验分享：with editor一个月、催稿两次，目前还没有消息，服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向：肿瘤;胃癌 经验分享：7.1投了一篇网状meta，7.2 with editor，持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：血液;肿瘤;综述 经验分享：2023.05.26投稿,3天后with editor,过了半个月还是with editor，于是发邮件催了一下， 2023.06.18 under review, 过了两个月还是没音信，就又催杂志社，没回应，本着破罐子破摔的想法，催了主编，没想到很快就给了小修（08.22），08.28返修回去，又是一直with editor，半个月后，还是with editor，等不及，又催了编辑，没反应，再催主编。 终于在2023.09.12 accept。 总结一下，这个杂志社只收综述，而且整个过程会很慢，编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：实体肿瘤;Review;血液肿瘤 经验分享：一审一个月，大修一个半月，小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0 偏重的研究方向：血液学 经验分享：审稿时间大概五个月，提了很多问题很详细，大修一个月，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153284, encodeId=e1d721532844c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：编辑处理一个月拒稿，这杂志的编辑真出生啊，7.13号投稿，期间邮件咨询状态3次全部没有回复，后来给主编发了邮件，第二天就拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2115702113, createdName=ms2000001247099710, createdTime=Thu Aug 17 19:57:43 CST 2023, time=2023-08-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2148767, encodeId=3f292148e67f2, content=他家只收综述么，科研论文不能投么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc148355026, createdName=ms6000001144568928, createdTime=Wed Jul 19 11:21:21 CST 2023, time=2023-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0 经验分享：投稿第二天就显示under review ，是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]

2020-07-02 怕种菜

审稿速度:6.0
偏重的研究方向：血液学
经验分享：审稿时间大概五个月，提了很多问题很详细，大修一个月，接收。

140 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向：肿瘤 经验分享：12月15日投稿，到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0 偏重的研究方向：综述;血液肿瘤 经验分享：with editor状态持续两个半月，然后直接拒稿，白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向：综述;血液肿瘤 经验分享：with editor一个月、催稿两次，目前还没有消息，服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向：肿瘤;胃癌 经验分享：7.1投了一篇网状meta，7.2 with editor，持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：血液;肿瘤;综述 经验分享：2023.05.26投稿,3天后with editor,过了半个月还是with editor，于是发邮件催了一下， 2023.06.18 under review, 过了两个月还是没音信，就又催杂志社，没回应，本着破罐子破摔的想法，催了主编，没想到很快就给了小修（08.22），08.28返修回去，又是一直with editor，半个月后，还是with editor，等不及，又催了编辑，没反应，再催主编。 终于在2023.09.12 accept。 总结一下，这个杂志社只收综述，而且整个过程会很慢，编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：实体肿瘤;Review;血液肿瘤 经验分享：一审一个月，大修一个半月，小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0 偏重的研究方向：血液学 经验分享：审稿时间大概五个月，提了很多问题很详细，大修一个月，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153284, encodeId=e1d721532844c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：编辑处理一个月拒稿，这杂志的编辑真出生啊，7.13号投稿，期间邮件咨询状态3次全部没有回复，后来给主编发了邮件，第二天就拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2115702113, createdName=ms2000001247099710, createdTime=Thu Aug 17 19:57:43 CST 2023, time=2023-08-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2148767, encodeId=3f292148e67f2, content=他家只收综述么，科研论文不能投么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc148355026, createdName=ms6000001144568928, createdTime=Wed Jul 19 11:21:21 CST 2023, time=2023-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0 经验分享：投稿第二天就显示under review ，是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]

2023-08-17 ms2000001247099710 来自湖南省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：药理
经验分享：编辑处理一个月拒稿，这杂志的编辑真出生啊，7.13号投稿，期间邮件咨询状态3次全部没有回复，后来给主编发了邮件，第二天就拒稿

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向：肿瘤 经验分享：12月15日投稿，到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0 偏重的研究方向：综述;血液肿瘤 经验分享：with editor状态持续两个半月，然后直接拒稿，白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向：综述;血液肿瘤 经验分享：with editor一个月、催稿两次，目前还没有消息，服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向：肿瘤;胃癌 经验分享：7.1投了一篇网状meta，7.2 with editor，持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：血液;肿瘤;综述 经验分享：2023.05.26投稿,3天后with editor,过了半个月还是with editor，于是发邮件催了一下， 2023.06.18 under review, 过了两个月还是没音信，就又催杂志社，没回应，本着破罐子破摔的想法，催了主编，没想到很快就给了小修（08.22），08.28返修回去，又是一直with editor，半个月后，还是with editor，等不及，又催了编辑，没反应，再催主编。 终于在2023.09.12 accept。 总结一下，这个杂志社只收综述，而且整个过程会很慢，编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：实体肿瘤;Review;血液肿瘤 经验分享：一审一个月，大修一个半月，小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0 偏重的研究方向：血液学 经验分享：审稿时间大概五个月，提了很多问题很详细，大修一个月，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153284, encodeId=e1d721532844c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：编辑处理一个月拒稿，这杂志的编辑真出生啊，7.13号投稿，期间邮件咨询状态3次全部没有回复，后来给主编发了邮件，第二天就拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2115702113, createdName=ms2000001247099710, createdTime=Thu Aug 17 19:57:43 CST 2023, time=2023-08-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2148767, encodeId=3f292148e67f2, content=他家只收综述么，科研论文不能投么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc148355026, createdName=ms6000001144568928, createdTime=Wed Jul 19 11:21:21 CST 2023, time=2023-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0 经验分享：投稿第二天就显示under review ，是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]

2023-07-19 ms6000001144568928

他家只收综述么，科研论文不能投么

32 0

[GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向：肿瘤 经验分享：12月15日投稿，到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175483, encodeId=7ee521e548311, content=审稿速度:3.0 偏重的研究方向：综述;血液肿瘤 经验分享：with editor状态持续两个半月，然后直接拒稿，白白浪费我三个月时间。谨慎投稿吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Sun Dec 17 18:32:36 CST 2023, time=2023-12-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向：综述;血液肿瘤 经验分享：with editor一个月、催稿两次，目前还没有消息，服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向：肿瘤;胃癌 经验分享：7.1投了一篇网状meta，7.2 with editor，持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：血液;肿瘤;综述 经验分享：2023.05.26投稿,3天后with editor,过了半个月还是with editor，于是发邮件催了一下， 2023.06.18 under review, 过了两个月还是没音信，就又催杂志社，没回应，本着破罐子破摔的想法，催了主编，没想到很快就给了小修（08.22），08.28返修回去，又是一直with editor，半个月后，还是with editor，等不及，又催了编辑，没反应，再催主编。 终于在2023.09.12 accept。 总结一下，这个杂志社只收综述，而且整个过程会很慢，编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：实体肿瘤;Review;血液肿瘤 经验分享：一审一个月，大修一个半月，小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0 偏重的研究方向：血液学 经验分享：审稿时间大概五个月，提了很多问题很详细，大修一个月，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153284, encodeId=e1d721532844c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：编辑处理一个月拒稿，这杂志的编辑真出生啊，7.13号投稿，期间邮件咨询状态3次全部没有回复，后来给主编发了邮件，第二天就拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2115702113, createdName=ms2000001247099710, createdTime=Thu Aug 17 19:57:43 CST 2023, time=2023-08-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2148767, encodeId=3f292148e67f2, content=他家只收综述么，科研论文不能投么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc148355026, createdName=ms6000001144568928, createdTime=Wed Jul 19 11:21:21 CST 2023, time=2023-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0 经验分享：投稿第二天就显示under review ，是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]

2021-11-16 capoex

投稿命中率:25.0
经验分享：投稿第二天就显示under review ，是真的送审了么

63 12

展开12条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务